We’re Answering Your Frequently Asked DSCSA Questions
Over the last year, the pharmacy supply chain has been bracing for DSCSA. While terms like, “interoperability” and “track and trace” have been swirling around the industry for a while now, there are still some misconceptions about what it means for pharmacies. This has only intensified after the FDA announced a stabilization period, which will be in effect until November 27, 2024. Although this provides pharmacies with more time, it does not mean there isn’t work to be done now. To ensure your pharmacy is ready for DSCSA, here are answers to your frequently asked questions:
What are the DSCSA/Interoperability requirements?
To achieve supply chain interoperability, all trading partners will need to establish secure, electronic data exchanges to track the entire path of a product. This means, serialized, unit-level data will need to accompany each prescription drug, every time it changes ownership, including:
• The unique product identifier, serial number, and expiration date.
• Detailed transaction information and a transaction summary.
As a result, pharmacies will need to be able to send and receive unit-level data for every drug purchased using the new Electronic Product Code Information Services (EPCIS) standard. Read more >
